SENSEX NIFTY

Glenmark Pharmaceuticals

Feb 21, 2017 at 17:36 | Source: PTI
Glenmark Pharmaceuticals today said it has received four observations from the US health regulator for its Ankleshwar facility after inspection in December 2016.
Feb 21, 2017 at 09:33 | Source: Moneycontrol.com
The company plans to invest a total of around USD 84 million for expansion. Of this, USD 68.5 million will be raised by debt, which includes a loan from World Bank arm International Finance Corporation.
Feb 15, 2017 at 13:22 | Source: CNBC-TV18
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Just Dial and sell Container Corporation of India and Glenmark Pharma.
Feb 15, 2017 at 11:48 | Source: CNBC-TV18
Sandeep Wagle of powermywealth.com is of the view that one can buy Adani Enterprises and Indraprastha Gas and advises selling Glenmark Pharma.
Feb 10, 2017 at 09:54 | Source: CNBC-TV18
In an interview to CNBC-TV18, Dipan Mehta, Member of BSE & NSE shared his readings and outlook on specific stocks and sector.
Feb 09, 2017 at 14:58 | Source: CNBC-TV18
Vijay Chopra of enochventures.com is of the view that one may hold Cipla.
Feb 08, 2017 at 17:24 | Source: Moneycontrol.com
Edelweiss recommended hold rating on Glenmark Pharmaceuticals with a target price of Rs 820 in its research report dated February 03, 2017.
Feb 08, 2017 at 16:08 | Source: Moneycontrol.com
Religare is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1110 in its research report dated February 03, 2017.
Feb 07, 2017 at 22:14 | Source: CNBC-TV18
Shereen Bhan speaks with top bosses from the pharma sector along with KT Rama Rao, Minister of IT, Telangana at Bioasia 2017 to discuss way forward for pharma sector in making India healthier.
Feb 07, 2017 at 12:28 | Source: Moneycontrol.com
ICICI Direct is bullish on Glenmark Pharma has recommended buy rating on the stock with a target price of Rs 1155 in its research report dated February 06, 2017.
Messages on Glenmark Pharmaceuticals »

Wire News

Platinum Member

713 Followers

News Now  

Glenmark Pharmaceuticals today said it has received four observations from the US health regulator for its Ankleshwar facility after inspection in December 2016.

5.36 PM Feb 21st

Forum Messenger

Platinum Member

376847 Followers

Glenmark  

What is your view on Glenmark Pharmaceuticals?

5.24 PM Feb 8th

BSE/NSE Announcer

Platinum Member

21367 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE that the Nomination & Remuneration Committee of the Company, at its meeting held on February 02, 2017 has allotted 41,875 stock options and cancelled 20,938 stock options pursuant to Employee Stock Options Scheme, 2016.The Options granted under

5.39 PM Feb 2nd

BSE/NSE Announcer

Platinum Member

21367 Followers

Glenmark  

GLENMARK:The Exchange has sought clarification from Glenmark Pharmaceuticals Limited with respect to announcement dated 02-Feb-2017, regarding the appointment of Mr. Harish Kuber (ACS 10973) as the Company Secretary and Compliance Officer of the Company with effect from February 02, 2017 upon

5.27 PM Feb 2nd

BSE/NSE Announcer

Platinum Member

21367 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange that the Board of Directors at their Meeting held on February 02, 2017 have approved the appointment of Mr. Harish Kuber (ACS 10973) as the Company Secretary and Compliance Officer of the Company with effect from February 02, 2017 upon

4.30 PM Feb 2nd

BSE/NSE Announcer

Platinum Member

21367 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE that the Board of Directors at their Meeting held on February 02, 2017 have approved the appointment of Mr. Harish Kuber as the Company Secretary and Compliance Officer of the Company with effect from February 02, 2017 upon the recommendation

4.17 PM Feb 2nd

BSE/NSE Announcer

Platinum Member

21367 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has announced the following results for the quarter ended December 31, 2016:The Un-audited Standalone results for the Quarter ended December 31, 2016The Company has posted a net profit of Rs. 7113.07 million for the quarter ended December 31, 2016

3.56 PM Feb 2nd

BSE/NSE Announcer

Platinum Member

21367 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

4.10 PM Jan 30th

BSE/NSE Announcer

Platinum Member

21367 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding "Details of Earnings Call slated for February 03, 2016".

3.58 PM Jan 30th

uuuthh

Platinum Member

6929 Followers

Nifty Pharma  

to boost spending by companies on research and development. Next week, investors will also look forward to the earnings of Cadila Healthcare, Glenmark Pharmaceuticals, and Pfizer. Shares of Glenmark Pharmaceuticals, which will report its earnings on Thursday and Dr Reddy`s Laboratories, which

7.42 PM Jan 29th

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.